IDiyas

For the Inventor, By the Inventor

Oelsted, Denmark

Kenneth Jensen

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 9.7

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Bagsvaerd, DK (2019 - 2020)
  • Oelsted, DK (2016 - 2024)
  • Delsted, DK (2024)

Company Filing History:

goldMedal10 out of 1,371 
 
Novozymes A/s
 patents
silverMedal1 out of 384 
 
Novozymes, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2016-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):
1. 11993762 - Polypeptides having alpha-mannan degrading activity and polynucleotides encoding same (2024-05-28),
2. 11946079 - Method for producing a protein hydrolysate using an endopeptidase and a carboxypeptidase (2024-04-02),
3. 11746366 - GH5 and GH30 in wet milling (2023-09-05),
4. 11254919 - Polynucleotide encoding polypeptide having carboxypeptidase activity (2022-02-22),
5. 10858637 - Polypeptides with lipase activity and polynucleotides encoding same (2020-12-08),
6. 10724054 - Use of serine proteases for improving ethanol yield (2020-07-28),
7. 10584325 - Cellobiohydrolase variants and polynucleotides encoding same (2020-03-10),
8. 10221406 - Cellobiohydrolase variants and polynucleotides encoding same (2019-03-05),
9. 9988616 - Polypeptides having xanthan degrading activity and polynucleotides encoding same (2018-06-05),
10. 9458441 - Polypeptides having xanthan degrading activity and polynucleotides encoding same (2016-10-04),

Title: Biography of Inventor Kenneth Jensen

Introduction: Kenneth Jensen is a notable inventor based in Oelsted, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and methods for protein hydrolysis. With a total of 10 patents to his name, Jensen's work has had a considerable impact on various applications in the industry.

Latest Patents: Among his latest patents is a composition involving polypeptides that exhibit alpha-mannan degrading activity. This invention encompasses the polypeptides themselves, as well as the polynucleotides that encode them. Additionally, he has developed a method for producing a protein hydrolysate using specific enzymes, including an endopeptidase and a carboxypeptidase. This method highlights the innovative use of these enzymes for hydrolyzing protein substrates.

Career Highlights: Kenneth Jensen has worked with prominent companies in the biotechnology sector, including Novozymes A/S and Novozymes, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development.

Collaborations: Throughout his career, Jensen has collaborated with esteemed colleagues such as Lorena G. Palmen and Tine Hoff. These partnerships have fostered a collaborative environment that has led to the advancement of innovative solutions in biotechnology.

Conclusion: Kenneth Jensen's contributions to the field of

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…